focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCLIN.L Share News (CLIN)

  • There is currently no data for CLIN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AIM WINNERS & LOSERS: Rockhopper rises as Navitas enters project

Wed, 08th Dec 2021 11:45

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

----------

AIM - WINNERS

----------

Rockhopper Exploration PLC, up 22% at 6.38 pence, 12-month range 4.50p-12.50p. The oil & gas exploration and production company says Navitas Petroleum LP is to enter its Sea Lion oil project in the Falkland Islands. Navitas replaces Harbour Energy PLC as Rockhopper's partner in the project.

----------

Equals Group PLC, up 12% at 70.40p, 12-month range 26.10p-73.00. The fintech payments firm says it has "significantly exceeded" its full-year expectations for both adjusted earnings and revenue. Group revenue for the year to date is GBP40.4 million, up 51% from GBP26.8 million for the same period in 2020. The strong revenue performance means increased gross profit and earnings, and Equals says it has exceeded its own full-year profitability forecasts, but does not provide a figure.

----------

Clinigen Group PLC, up 10% at 901.00p, 12-month range 541.50p-912.00p. Shares hit 12-month high after the pharmaceuticals and services provider agrees to be taken private by European investment firm Triton Funds in a GBP1.2 billion deal. Under the terms, Clinigen shareholders will receive 883p a share in cash. This is a 41% premium to the ex-dividend closing share price on December 1, which was the last business day before takeover talks were first announced. Clinigen shareholders will also be entitled to receive the previously declared final dividend of 5.46p a share.

----------

AIM - LOSERS

----------

Byotrol PLC, down 16% at 4.22p, 12-month range 4.00p-7.70p. Shares in the antimicrobial technologies company hit fresh 12-month low after profit warning and says its first half performance was below expectations. For six months to September 30, swings to pretax loss of GBP141,000 from GBP1.0 million profit year before. "Whilst we expect to be both profitable and cash generative in the second half of the year, with these uncertainties it is difficult to predict the quantum at this juncture. At present we are expecting IP sales to offset the majority of the anticipated shortfall in profit on product sale, but projecting the timing of IP sales is even more uncertain, so we feel it prudent to now reduce market guidance for the current financial year," it says.

----------

By Arvind Bhunjun; arvindbhunjun@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
10 Oct 2019 10:50

Clinigen Inks Partnership To Sell Tumor Treatment Azedra Outside US

Clinigen Inks Partnership To Sell Tumor Treatment Azedra Outside US

Read more
3 Oct 2019 09:34

BROKER RATINGS SUMMARY: Peel Hunt Raises Flutter Entertainment To Hold

BROKER RATINGS SUMMARY: Peel Hunt Raises Flutter Entertainment To Hold

Read more
30 Sep 2019 09:55

BROKER RATINGS SUMMARY: Barclays Cuts Whitbread And Raises SSE

BROKER RATINGS SUMMARY: Barclays Cuts Whitbread And Raises SSE

Read more
19 Sep 2019 13:29

Thursday broker round-up

(Sharecast News) - Ferguson: RBC Capital Markets downgrades to underperform with a target price of 5,100p.

Read more
19 Sep 2019 10:36

Clinigen Profit Drops On One-Off Costs, Despite Strong Revenue Growth

(Alliance News) - Clinigen Group PLC said Thursday annual profit dropped sharply on higher amortisation costs on acquired intangibles and acquisition expenses, despite strong revenue the financial

Read more
12 Sep 2019 16:21

UK Earnings, Trading Statements Calendar - Next 7 Days

Friday 13 September  JD WetherspoonFull Year ResultsSthreeQ3 Enterprise Investment

Read more
16 Jul 2019 10:04

Clinigen Expects Increased Annual Profit On Strong Acquisitions

(Alliance News) - Clinigen Group PLC said Thursday it expects to see a double-digit rise in profit and revenue for its recently ended financial year, driven by contributions from the year to the a

Read more
16 May 2019 06:45

CORRECT: Clinigen Retakes Ethyol And Totect US Commercial Rights

(Correcting the headline to clarify that Clinigen already had the products in its portfolio).LONDON (Alliance News) - Clinigen Group PLC on Wednesday said it has agreed to retake the US to

Read more
15 May 2019 12:43

Clinigen to take back US rights to cancer drugs

(Sharecast News) - Aim's Clinigen Group is taking back control of two oncology drugs from US partner Cumberland Pharmaceuticals.

Read more
2 Apr 2019 10:57

Clinigen monopolises global rights for skin cancer treatment

(Sharecast News) - Clinigen now owns the global rights to Proleukin after having acquired the US rights to the treatment on Tuesday following US anti-trust clearance.

Read more
27 Feb 2019 10:23

Clinigen earnings grow following CSM and iQone acquisitions

(Sharecast News) - Specialty pharmaceuticals group Clinigen saw strong earnings and cash flow growth in the first half of its trading year following a period of transformative acquisitions.

Read more
27 Feb 2019 08:55

Clinigen Group Reports "Good" Interim Performance As Revenue Rises

LONDON (Alliance News) - Clinigen Group PLC on Wednesday described its interim performance as "good", with revenue rising 24%, but profit did fall on the prior year.For the six to

Read more
20 Feb 2019 16:10

UK Earnings, Trading Statements Calendar - Next 7 Days

Thursday 21 February BAE SystemsFull Year ResultsRELXFull Year Year AmericanFull

Read more
20 Feb 2019 13:19

Wednesday broker round-up

(Sharecast News) - Ocado: Peel Hunt downgrades to hold with a target price of 110p.

Read more
13 Feb 2019 12:50

Wednesday broker round-up

(Sharecast News) - Workspace Group: Berenberg downgrades to hold with a target price of 900p.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.